The resultant leptin : adiponectin ratio was 2.5-fold higher in NASH subjects than controls (3.22 ± 0.5 vs. 1.27 ± 0.4; p = 0.0032). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.